ArticleThe Lancet. Microbe2024

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.

Susan Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.